Earningsreport

Q3/2023 9/30/2023 EPS -0.390 ZacksConsensus -0.400 ActVsEst 0.010 - Beat

Altimmune, Inc.  (ALT) 
NASDAQ:AMEX Investor Relations: altimmune.com/investors